Fennell, Dean A. http://orcid.org/0000-0001-7373-1312
Bzura, Aleksandra
Article History
First Online: 23 August 2022
Competing interests
: D.A.F. has received research grants from Astex Therapeutics, Bayer, Bristol Myers Squibb, Boehringer Ingelheim and Pierre Fabre; fees from Aldeyra, Atara Biotherapeutics, Bristol Myers Squibb, Cambridge Clinical Laboratories, Inventiva and Targovax; and non-financial support from Clovis, Eli Lilly, Roche, Bergen Bio, Bristol Myers Squibb, MSD and Pierre Fabre.